We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-1.00 | -0.07% | 1,334.00 | 1,334.00 | 1,334.50 | 1,337.50 | 1,333.00 | 1,335.00 | 354,059 | 09:23:52 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 30.33B | 4.93B | 1.1889 | 11.22 | 55.34B |
Date | Subject | Author | Discuss |
---|---|---|---|
14/2/2022 19:51 | It is for someone who has 50 shares ! | abdullla | |
14/2/2022 17:44 | Crashing? Grow up. This isn't a crash. | pander45 | |
14/2/2022 16:07 | Was fine earlier | spoole5 | |
14/2/2022 16:01 | Is it time buy | jretlaw | |
14/2/2022 15:37 | This sudden drop could also be due to the Ftse crashing | abdullla | |
14/2/2022 15:22 | Researchers from GlaxoSmithKline (GSK) say that they are on the verge of a breakthrough in creating the world’s first vaccine against the deadly RSV. Within months, the world could have the data needed for a vaccine that targets the deadly virus that hospitalises and kills thousands of Britons every winter. RSV particularly affects children and the elderly, and currently, there is no vaccine or treatment against it. GSK believes that it is just "months away" from publishing its report that will show that its RSV jab is safe and effective. While the report is due early this year, the vaccine will likely be approved and put into use by next winter. | tradermichael | |
14/2/2022 15:05 | It may be something to do with the transfer of treasury shares as mentioned in RNS | abdullla | |
14/2/2022 15:03 | Camera crew just arrived at Head Office - market suspects Emma may be about to open her mouth | watfordhornet | |
14/2/2022 15:00 | Considering it was 12000 just a short while back you can hardly call it a crash. Probably just a bit of profit-taking in case the balloon goes up. | netcurtains | |
14/2/2022 14:58 | Why the sudden crash in the share price?? | abdullla | |
14/2/2022 14:38 | And there's the 1500s. We'll done Emma | spoole5 | |
14/2/2022 12:48 | You could say Mr.Goldfinger was a "goldbug" in the Jamesbond film . | abdullla | |
14/2/2022 11:24 | In what sense? Certainly not share price. | patientcapital | |
14/2/2022 09:27 | "Gold bug" (sometimes spelled "goldbug") is a term frequently employed in the financial sector and among economists in reference to persons who are extremely bullish on the commodity gold as an investment and or a standard for measuring wealth. | tradermichael | |
14/2/2022 08:56 | Whats a goldbug? Does anyone know? | netcurtains | |
14/2/2022 07:28 | rossannan- just seen your same post on AAU. Why are you posting here unless you thought GSK was a miner? | 2vdm | |
13/2/2022 15:15 | Thanks zho. I'm sure he had his reasons, but doesn't inspire confidence for future. All we need now is for Hal to dump a load of his. | jonjoneil | |
13/2/2022 15:07 | It was RNSed on Friday: | zho | |
13/2/2022 15:02 | TM Why no name or source? | jonjoneil | |
13/2/2022 14:44 | GSK consumer chief sells USD2.5 million in Glaxo shares | tradermichael | |
12/2/2022 23:34 | Not this time. Patience is required. | maxplus2 | |
12/2/2022 23:33 | When you sell it on Ex-Divi day, the price drops by an amount relating to dividend | maxplus2 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions